5YR企业会员
产品目录
推荐产品更多
妥布霉素EP杂质B;妥布霉素EP杂质B,尼布拉明
询价
更新时间:2026/05/25
沙丁胺醇ep杂质F;沙丁胺醇杂质F,二聚体
询价
更新时间:2026/05/25
苯肾上腺素异构体杂质;苯肾上腺素S异构体,S-苯肾上腺素
询价
更新时间:2026/05/25
阿米卡星杂质H
询价
更新时间:2026/05/25
艾沙康唑杂质31 (BAL30145)
询价
更新时间:2026/05/25
倍他米松杂质45;倍他米松磷酸钠杂质;倍他米松磷酸钠碱降解杂质
询价
更新时间:2026/05/25
林可霉素EP杂质C;N-去甲基林可霉素
询价
更新时间:2026/05/25
托法替尼(3R,5S)异构体;非对应异构体CP-733,317
询价
更新时间:2026/05/25
5-羟基沙丁胺醇
询价
更新时间:2026/05/25
阿莫罗芬EP杂质E;
询价
更新时间:2026/05/25
公司介绍
深圳振强药物研发有限公司
小微企业
QUALITY CONTROL SOLUTIONS LTD(QCS Pharmaceutical R&D Center)—Global Leader in Pharmaceutical Reference Materials Research & Development and Innovation Platform A globally integrated, internationalized innovation platform dedicated to the research, development, and commercialization of pharmaceutical reference materials and impurities. QCS is committed to delivering high-purity, fully traceable, and rigorously standardized reference substances—as well as tailored small-molecule solutions—to the global pharmaceutical industry. The company operates under the dual foundational accreditations of ISO 17034 (for certified reference material producers) and ISO 9001 (for quality management systems), and has established a comprehensive, end-to-end technical ecosystem spanning research, manufacturing, and analytical testing. QCS serves more than 5,000 pharmaceutical enterprises across over 100 countries, with its portfolio encompassing 100,000+ reference materials for active pharmaceutical ingredients (APIs), metabolites, degradation products, and related impurities. The QCS brand achieves annual global sales exceeding RMB 100 million, employs a team of over 170 highly skilled professionals, and maintains a robust presence in all major pharmaceutical markets worldwide.
公司成立时间 2021/7/26 0:00:00
注册资本 500万人民币
员工人数 50-100人
年营业额 ¥ 1亿以上
经营模式 贸易,试剂,定制,服务
主营行业 标准品和对照品
主营产品 医药标准品,杂质对照品,定制合成服务
经营范围 一般经营项目是:医学研究和试验发展;生物化工产品技术研发;专用化学产品制造(不含危险化学品);实验分析仪器销售;电子产品销售;化工产品销售(不含许可类化工产品);专用化学产品销售(不含危险化学品);技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广;国内贸易代理。(除依法须经批准的项目外,凭营业执照依法自主开展经营活动),许可经营项目是:检验检测服务;货物进出口;技术进出口。(依法须经批准的项目,经相关部门批准后方可开展经营活动,具体经营项目以相关部门批准文件或许可证件为准)
公司动态更多
2024V27 | 抗精神病药-依匹哌唑(Brexpiprazole)特异性杂质稳定性研究分享
2024/9/26 10:40:31
2024V26 | JAK抑制剂-乌帕替尼(Upadacitinib)特异性杂质稳定性研究
2024/9/20 14:04:56
2024V25 | 早泄治疗药-达泊西汀(Dapoxetine)特异性杂质稳定性研究分享
2024/9/19 15:24:18
联系方式
电话: 查看联系方式
邮箱:export03@qcsrm.com
地址:B3-301A,401,402 LIFE SCIENCE PARK, SCT CREATIVE FACTORY PINGSHAN DISTRICT, SHENZHEN, CHINA
CB指数:58